Paper · 168488
Predominantly T-cell infiltrate in rheumatoid synovial membranes.
Van Boxel JA and 1 other. N Engl J Med, 1975. Cited by 369 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Predominantly T-cell infiltrate in rheumatoid synovial membranes. Papers, record 168488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/168488
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Synovial Membrane | Major topic |
| T-Lymphocytes | Major topic |
| Adolescent | |
| Binding Sites, Antibody | |
| Cell Separation | |
| Complement C3 | |
| Deoxyribonucleases | |
| Female | |
| Humans | |
| Immune Adherence Reaction | |
| Lymphocytes | |
| Male | |
| Microbial Collagenase | |
| Middle Aged | |
| Receptors, Antigen, B-Cell | |
| Synovitis |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 369 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,613,106 | Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41613106 | PubMed |
| 38,336,809 | Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/38336809 | PubMed |
| 37,893,571 | Rheumatoid Arthritis Has Won the Battle but Not the War: How Many Joints Will We Save Tomorrow? | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37893571 | PubMed |
| 35,210,510 | Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis. | Sci Rep | 2022 | https://conductscience.org/library/papers/35210510 | PubMed |
| 34,394,100 | Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34394100 | PubMed |
| 33,680,781 | Incisionless Synovium and Bone Biopsy of a Painful Total Knee Arthroplasty. | Arthrosc Tech | 2021 | https://conductscience.org/library/papers/33680781 | PubMed |
| 33,504,785 | Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation. | Nat Commun | 2021 | https://conductscience.org/library/papers/33504785 | PubMed |
| 33,229,974 | Rheumatology in the era of precision medicine: synovial tissue molecular patterns and treatment response in rheumatoid arthritis. | Curr Opin Rheumatol | 2021 | https://conductscience.org/library/papers/33229974 | PubMed |
| 31,938,116 | Knockdown of LSD1 ameliorates the severity of rheumatoid arthritis and decreases the function of CD4 T cells in mouse models. | Int J Clin Exp Pathol | 2018 | https://conductscience.org/library/papers/31938116 | PubMed |
| 30,765,202 | IL-17 and limits of success. | Cell Immunol | 2019 | https://conductscience.org/library/papers/30765202 | PubMed |
1 to 10 of 114
See all 114 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/168488
GET https://conductscience.org/api/papers/v1/168488/cited_by?page=2